Development of an automated platform for the optimal production of glycoconjugate vaccines expressed in Escherichia coli. (2021)

First Author: Samaras JJ
Attributed to:  The Future Vaccine Manufacturing Research Hub (Vax-Hub) funded by EPSRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1186/s12934-021-01588-1

PubMed Identifier: 34030723

Publication URI: http://europepmc.org/abstract/MED/34030723

Type: Journal Article/Review

Volume: 20

Parent Publication: Microbial cell factories

Issue: 1

ISSN: 1475-2859